Comparative effects of nabumetone, sulindac, and ibuprofen on renal function

Journal of Rheumatology

Volumn 24, Issue 6, 1997, Pages 1137-1144

  Cook, M Eileen ^b   Wallin, J David ^e   Thakur, Vashu D ^a   Kadowitz, Philip J ^b   McNamara, Dennis B ^b   Garcia, Meredith M ^c   Lipani, John A ^d   Poland, Marcia ^d  

^a LSU Medical School   (United States)

^b Department of Pharmacology ^*

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SmithKline Beecham   (United States)

^e LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Afferent arteriolar tone; Glomerular hydrostatic pressure; Nonsteroidal antiinflammatory drugs; Prostaglandins; Renal function

Indexed keywords

FOSINOPRIL; HYDROCHLOROTHIAZIDE; IBUPROFEN; NABUMETONE; SULINDAC;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANONES; CROSS-OVER STUDIES; ELECTROLYTES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IBUPROFEN; KIDNEY; MIDDLE AGED; PROSTAGLANDINS; SULINDAC; THROMBOXANE B2;

EID: 0030978762     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Clive DM, Stoff JS: Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984;310:563-72.
2. Berg KG: Acute effects of acetylsalicylic acid on renal function in normal man. Eur J Clin Pharmacol 1977;11:117-23.
3. Donker AJM, Arisz L, Brentjens JRH, van der Hem GK, Hollemans HJG: The effect of indomethacin on kidney function and plasma renin activity in man. Nephron 1976;17:288-96.
4. 1 on renal hemodynamics, sodium and water excretion. Am J Physiol 1967;213:939-46.
5. Brater DC: Effect of indomethacin on salt and water homeostasis. Clin Pharmacol Ther 1979;25:322-30.
6. Tan Sy, Shapiro R, Franco R, Stockard H, Mulrow PJ: Indomethacin induced prostaglandin inhibition with hyperkalemia: A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med 1979;90:783-5.
7. MacCarthy EP, Frost GW, Stokes GS: Indomethacin-induced hyperkalemia. Med J Aust 1979;1:550.
8. Brezin JH, Katz SM, Schwartz AB, Chinitz JL: Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 1979;301:1271-3.
9. Rennke HG, Roos PC, Wall SG: Drug-induced interstitial nephritis with heavy glomerular proteinuria. N Engl J Med 1980;302:691-2.
10. Shah GM, Muhalwas KK, Winer RL: Renal papillary necrosis due to ibuprofen. Arthritis Rheum 1981;24:1208-10.
11. Husserl FE, Lange RK, Kantrow CM Jr: Renal papillary necrosis and pyelonephritis accompanying fenoprofen therapy. JAMA 1979;242:1896-8.
12. 1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 1979;11:215-22.
13. Arisz L, Donker AJM, Brentjens JRH, van der Hem GK: The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome. Acta Med Scand 1976;199:121-5.
14. Blackshear JL, Davidman M, Stillman MT: Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med 1983;143:1130-4.
15. Rumpt KW, Frenzel S, Lowitz HD, Scheler F: The effect of indomethacin on plasma renin activity in man under normal conditions and after stimulation of the renin angiotensin system. Prostaglandins 1975;10:641-8.
16. Dunn MJ, Hood VL: Prostaglandins and the kidney. Am J Physiol 1977;233:F169-84.
17. Brandi DW, Sarkissian E, Ng SC, Paulus HE: Pharmacokinetics and drug disposition. Individual variability in concentrations of urinary sulindac sulfide. Clin Pharmacol Ther 1991;50:650-5.
18. Eriksson LO, Sturfelt G, Thysell H, Wollheim FA: Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis. Am J Med 1990;89:313-21.
19. Freed MI, Audet PR, Zariffa N, et al: Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers. J Clin Pharmacol 1994;34:1098-108.
20. Wasserman: Latin square designs. Applied Linear Statistical Models. Chicago, R.D. Irwin, 1974:792-3.
21. Campbell WB, Ojeda SR: Measurement of prostaglandins by radioimmunoassay. Methods Enzymol 1987;141:323-41.
22. Walser M, Davidson DG, Orloff J: The renal clearance of alkali stable inulin. J Clin Invest 1955;34:1520-3.
23. Smith HW, Finkelstein N, Aliminosa L, et al: The renal clearances of substitute hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945;24:388-404.
24. Gomez DM: Evaluation of renal resistances, with special reference to changes in essential hypertension. J Clin Invest 1951;30:1143-55.
25. Whelton A, Stout RL, Spilman PS, Klassen DK: Renal effects of ibuprofen, piroxicam and sulindac in patients with asymptomatic renal failure. Ann Intern Med 1990;112:568-76.
26. Aronoff GR: Therapeutic implications associated with renal studies of nabumetone. J Rheumatol 1992;(suppl 36)19:25-31.
27. Laneuville O, Brever DK, DeWitt DL, et al: Differential inhibition of human prostaglandin endoperoxide H synthesis-1 cd-2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994;271:927-34.